[
  {
    "title": "How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created",
    "link": "https://finance.yahoo.com/m/c37dd58a-9df5-3bbb-ab19-ad6960602b88/how-ozempic%E2%80%99s-maker-lost-its.html"
  },
  {
    "title": "Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer",
    "link": "https://finance.yahoo.com/news/eli-lilly-expand-pain-pipeline-152700804.html"
  },
  {
    "title": "Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?",
    "link": "https://finance.yahoo.com/news/eli-lilly-vs-astrazeneca-pharma-132200801.html"
  },
  {
    "title": "Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position”",
    "link": "https://finance.yahoo.com/news/jim-cramer-notes-eli-lilly-215430668.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-200113091.html"
  },
  {
    "title": "Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition",
    "link": "https://finance.yahoo.com/news/eli-lilly-targets-pain-management-192507570.html"
  },
  {
    "title": "Eli Lilly Strikes up to $1 Billion Deal for SiteOne Therapeutics in Bid to Grow Pain Drug Pipeline",
    "link": "https://finance.yahoo.com/news/eli-lilly-strikes-1-billion-191201567.html"
  },
  {
    "title": "Eli Lilly to expand pain pipeline with $1bn SiteOne buyout",
    "link": "https://finance.yahoo.com/news/eli-lilly-expand-pain-pipeline-172558854.html"
  },
  {
    "title": "Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics",
    "link": "https://finance.yahoo.com/news/eli-lilly-expands-pain-pipeline-145934309.html"
  },
  {
    "title": "What’s the Price Outlook for Weight-Loss Drugs?",
    "link": "https://finance.yahoo.com/m/bcea9aa1-f326-34f6-93cd-53ef9fcd2272/what%E2%80%99s-the-price-outlook-for.html"
  },
  {
    "title": "Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics",
    "link": "https://finance.yahoo.com/news/lilly-expand-pain-pipeline-acquisition-140000869.html"
  },
  {
    "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-130013816.html"
  },
  {
    "title": "Lilly to buy pain drug developer SiteOne, challenging Vertex",
    "link": "https://finance.yahoo.com/news/lilly-buy-pain-drug-developer-123000105.html"
  },
  {
    "title": "Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly",
    "link": "https://finance.yahoo.com/news/heres-pharmaceutical-import-tariffs-could-084400494.html"
  },
  {
    "title": "Prediction: These 2 Stocks Will Beat the Market in the Next Decade",
    "link": "https://finance.yahoo.com/news/prediction-2-stocks-beat-market-074600349.html"
  },
  {
    "title": "Should Everyone Be Taking Ozempic? Doctors Say More People Could Benefit",
    "link": "https://finance.yahoo.com/m/9ec7e5e6-159e-32cf-9588-4f566bd1054d/should-everyone-be-taking.html"
  },
  {
    "title": "Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle",
    "link": "https://finance.yahoo.com/news/why-hims-hers-health-stock-180500075.html"
  },
  {
    "title": "3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies",
    "link": "https://finance.yahoo.com/news/3-stocks-targeting-weight-loss-151300377.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-eli-124200981.html"
  },
  {
    "title": "These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Axon Tops Buy Point",
    "link": "https://finance.yahoo.com/m/2b47c372-177e-3051-aa01-406a8d82b220/these-7-stocks-are-analyst.html"
  },
  {
    "title": "2 Growth Stocks to Own for Decades and 1 to Steer Clear Of",
    "link": "https://finance.yahoo.com/news/2-growth-stocks-own-decades-043336829.html"
  },
  {
    "title": "Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs",
    "link": "https://finance.yahoo.com/news/cigna-announced-agreement-copay-caps-021100886.html"
  },
  {
    "title": "Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting",
    "link": "https://finance.yahoo.com/news/lilly-announces-details-presentations-2025-210500920.html"
  },
  {
    "title": "Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-eli-lilly-203400904.html"
  },
  {
    "title": "Cigna takes different approach with GLP-1s, more favorable for Eli Lilly",
    "link": "https://finance.yahoo.com/news/cigna-takes-different-approach-glp-180959857.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Wins Approval For Alzheimer's Drug Kisunla In Australia",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-wins-173009800.html"
  },
  {
    "title": "Novo Nordisk battles Wegovy copycats through discounted prices, legal threats",
    "link": "https://finance.yahoo.com/news/novo-nordisk-battles-wegovy-copycats-through-discounted-prices-legal-threats-140138977.html"
  },
  {
    "title": "Did Eli Lilly Just Say Checkmate to Novo Nordisk?",
    "link": "https://finance.yahoo.com/news/did-eli-lilly-just-checkmate-120000332.html"
  },
  {
    "title": "Wegovy and Zepbound costs capped at $200 in new Evernorth programme",
    "link": "https://finance.yahoo.com/news/wegovy-zepbound-costs-capped-200-115631441.html"
  },
  {
    "title": "Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays",
    "link": "https://finance.yahoo.com/news/evernorth-reaches-deals-novo-nordisk-111436912.html"
  },
  {
    "title": "Lilly’s Kisunla marketing for Alzheimer’s authorised in Australia",
    "link": "https://finance.yahoo.com/news/lilly-kisunla-marketing-alzheimer-authorised-111001765.html"
  },
  {
    "title": "Lilly's Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer's disease",
    "link": "https://finance.yahoo.com/news/lillys-kisunla-donanemab-receives-marketing-202100783.html"
  },
  {
    "title": "Lilly’s former small molecule head makes the leap to a rising biotech in obesity",
    "link": "https://finance.yahoo.com/news/lilly-former-small-molecule-head-080000731.html"
  },
  {
    "title": "Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race",
    "link": "https://finance.yahoo.com/news/novo-nordisk-places-bet-ceo-174932675.html"
  },
  {
    "title": "Novo Nordisk Shares Dip 3% on Sudden CEO Transition Announcement",
    "link": "https://finance.yahoo.com/news/novo-nordisk-shares-dip-3-141500139.html"
  },
  {
    "title": "Novo Nordisk (NVO) Slides After CEO Departure; Analyst Flags Deeper Strategic Concerns",
    "link": "https://finance.yahoo.com/news/novo-nordisk-nvo-slides-ceo-122234659.html"
  },
  {
    "title": "3 Stocks Estimated To Be Trading Up To 49.2% Below Intrinsic Value",
    "link": "https://finance.yahoo.com/news/3-stocks-estimated-trading-49-114452087.html"
  },
  {
    "title": "Novo Nordisk’s CEO to step down as weight loss market share plummets",
    "link": "https://finance.yahoo.com/news/novo-nordisk-ceo-step-down-112302799.html"
  },
  {
    "title": "Judge shuts down drugmakers’ 340B rebate plans, for now",
    "link": "https://finance.yahoo.com/news/judge-shuts-down-drugmakers-340b-085824885.html"
  },
  {
    "title": "Eli Lilly and Co (LLY): Expands Genetic Hearing Loss Pipeline with $1.3B RNA Therapy Partnership",
    "link": "https://finance.yahoo.com/news/eli-lilly-co-lly-expands-212806633.html"
  },
  {
    "title": "Trump administration not backing down on Big Pharma pressure campaign",
    "link": "https://finance.yahoo.com/news/trump-administration-not-backing-down-on-big-pharma-pressure-campaign-133031848.html"
  },
  {
    "title": "Analysis-Novo Nordisk should look to the US for its next CEO, analysts say",
    "link": "https://finance.yahoo.com/news/analysis-novo-nordisk-look-us-194938893.html"
  },
  {
    "title": "From insulin to Ozempic, history of Novo Nordisk's CEOs",
    "link": "https://finance.yahoo.com/news/insulin-ozempic-history-novo-nordisks-181746441.html"
  },
  {
    "title": "Eli Lilly strikes $1.3bn gene therapy deal with Rznomics",
    "link": "https://finance.yahoo.com/news/eli-lilly-strikes-1-3bn-172248128.html"
  },
  {
    "title": "Galaxy Digital on the Nasdaq, Novo ousts CEO, Virgin Galactic",
    "link": "https://finance.yahoo.com/video/galaxy-digital-nasdaq-novo-ousts-171317433.html"
  },
  {
    "title": "Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price",
    "link": "https://finance.yahoo.com/m/bbb82497-a426-3bce-81c3-efa6923f220d/novo-nordisk-sheds-3-after.html"
  },
  {
    "title": "Novo Nordisk Boots CEO After Stock Falls 50%. It’s an Unusual Move for the Wegovy Drugmaker.",
    "link": "https://finance.yahoo.com/m/cbe23a34-99be-3764-85b5-5b5712cca95e/novo-nordisk-boots-ceo-after.html"
  },
  {
    "title": "Ozempic boss sacked after falling behind in weight-loss race",
    "link": "https://finance.yahoo.com/news/ozempic-boss-sacked-falling-behind-135810489.html"
  },
  {
    "title": "Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-stock-gains-14-130700689.html"
  },
  {
    "title": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-trending-130014866.html"
  },
  {
    "title": "Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker",
    "link": "https://finance.yahoo.com/news/novo-nordisk-ceo-steps-down-in-surprise-move-as-market-challenges-weigh-on-obesity-drugmaker-124922061.html"
  },
  {
    "title": "Wall Street Expects This Obesity Drug Stock to Skyrocket 35% Over the Next 12 Months",
    "link": "https://finance.yahoo.com/news/wall-street-expects-obesity-drug-084700542.html"
  },
  {
    "title": "ETFs to Capitalize on the Novo Nordisk-Septerna Deal",
    "link": "https://finance.yahoo.com/news/etfs-capitalize-novo-nordisk-septerna-140000288.html"
  },
  {
    "title": "Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk",
    "link": "https://finance.yahoo.com/news/septerna-stock-surges-oral-obesity-124600006.html"
  },
  {
    "title": "2 Stocks That Plummeted During President Trump's First 100 Days in Office, and Where They Could Be Headed",
    "link": "https://finance.yahoo.com/news/2-stocks-plummeted-during-president-085500477.html"
  },
  {
    "title": "3 Market-Beating Stocks with Promising Prospects",
    "link": "https://finance.yahoo.com/news/3-market-beating-stocks-promising-043848634.html"
  },
  {
    "title": "LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price Pressures",
    "link": "https://finance.yahoo.com/news/lly-q1-earnings-call-revenue-223159764.html"
  },
  {
    "title": "RFK Jr. Attacks Health Agency, Defends Cuts Before Congress",
    "link": "https://finance.yahoo.com/news/rfk-jr-plans-defend-health-114541807.html"
  },
  {
    "title": "Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-tumble-rival-212026703.html"
  },
  {
    "title": "Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert",
    "link": "https://finance.yahoo.com/news/healthcare-worst-performing-sp-500-subsector-year-to-date-mizuho-expert-155933705.html"
  },
  {
    "title": "Novo Nordisk Rises on Weight-Loss News. It’s a Huge Deal for This Stock.",
    "link": "https://finance.yahoo.com/m/93df1f34-401c-3cbb-bd46-28d8b34ff523/novo-nordisk-rises-on.html"
  },
  {
    "title": "Jim Cramer on Eli Lilly and Company (LLY) – “Buy Hand Over Fist – This GLP-1 Giant Just Crushed Novo”",
    "link": "https://finance.yahoo.com/news/jim-cramer-eli-lilly-company-141639217.html"
  },
  {
    "title": "Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna",
    "link": "https://finance.yahoo.com/news/novo-nordisks-latest-bet-on-obesity-pills-22-billion-for-biotech-septerna-133232315.html"
  },
  {
    "title": "Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?",
    "link": "https://finance.yahoo.com/news/lilly-down-17-since-q1-125100333.html"
  },
  {
    "title": "Why Eli Lilly and Company (LLY) Is The Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-company-lly-210927250.html"
  },
  {
    "title": "Trump's EO Targets Big Pharma Stocks like Eli Lilly",
    "link": "https://finance.yahoo.com/news/trumps-eo-targets-big-pharma-203600990.html"
  },
  {
    "title": "Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...",
    "link": "https://finance.yahoo.com/news/sangamo-therapeutics-inc-sgmo-q1-170101803.html"
  },
  {
    "title": "PFE vs. LLY: Which Stock Is the Better Value Option?",
    "link": "https://finance.yahoo.com/news/pfe-vs-lly-stock-better-154010141.html"
  },
  {
    "title": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
    "link": "https://finance.yahoo.com/m/23918c9e-3c4d-3cd4-9d90-726c71a99d5f/pfizer-eli-lilly-and-other.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-j-132200138.html"
  },
  {
    "title": "Why Lilly (LLY) International Revenue Trends Deserve Your Attention",
    "link": "https://finance.yahoo.com/news/why-lilly-lly-international-revenue-131622489.html"
  },
  {
    "title": "How Hims & Hers survived the great Spac shakeout",
    "link": "https://finance.yahoo.com/news/hims-hers-survived-great-spac-124605022.html"
  },
  {
    "title": "RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US",
    "link": "https://finance.yahoo.com/news/rhhby-invest-1-25b-boost-122100081.html"
  },
  {
    "title": "Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared",
    "link": "https://finance.yahoo.com/news/drug-stocks-recover-trumps-order-113600111.html"
  },
  {
    "title": "Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-buy-sell-040209659.html"
  },
  {
    "title": "Trump's drug price order is part request, part threat: Analyst",
    "link": "https://finance.yahoo.com/video/trumps-drug-price-order-part-232000676.html"
  },
  {
    "title": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
    "link": "https://finance.yahoo.com/m/8bbeb00f-58ab-3bfb-8fe9-492a82597341/s-p-dow-pharma-stocks.html"
  },
  {
    "title": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "link": "https://finance.yahoo.com/m/1b14d492-f15c-39ae-a253-f4ee9a3ca80b/these-stocks-moved-the-most.html"
  },
  {
    "title": "Trump calls out weight-loss drugs as target of price-cut push",
    "link": "https://finance.yahoo.com/news/trump-calls-weight-loss-drugs-200934779.html"
  },
  {
    "title": "How Trump could go about executing order to slash drug prices",
    "link": "https://finance.yahoo.com/video/trump-could-executing-order-slash-195046744.html"
  },
  {
    "title": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "link": "https://finance.yahoo.com/m/987352d5-6779-36ef-9e14-e8db473744e8/trump-executive-order-could.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Announces Superior Weight Loss Results for Zepbound Over Wegovy",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-announces-171706899.html"
  },
  {
    "title": "Fox One, SoftBank delays investment, Zepbound weight loss",
    "link": "https://finance.yahoo.com/video/fox-one-softbank-delays-investment-161429351.html"
  },
  {
    "title": "Eli Lilly stock sinks as pharma misses out on the market rally",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-sinks-pharma-150800594.html"
  },
  {
    "title": "Trump expected to sign order to slash US drug prices",
    "link": "https://finance.yahoo.com/video/trump-expected-sign-order-slash-144432389.html"
  },
  {
    "title": "Novo Nordisk Stock Is Slumping Today. Here’s Why.",
    "link": "https://finance.yahoo.com/m/58e354c4-a2cd-3585-994d-af41ca5f1206/novo-nordisk-stock-is.html"
  },
  {
    "title": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
    "link": "https://finance.yahoo.com/video/mag-7-rally-airline-pharmaceutical-140147890.html"
  },
  {
    "title": "Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy",
    "link": "https://finance.yahoo.com/m/dc6e699a-d88f-358b-b255-eccaf6004dbf/eli-lilly-says-trial-patients.html"
  },
  {
    "title": "US-China trade truce, April CPI, drug prices: 3 Things",
    "link": "https://finance.yahoo.com/video/us-china-trade-truce-april-130939738.html"
  },
  {
    "title": "Novo Nordisk Tumbles as Lilly's  Zepbound Shows Greater Weight Loss in Trial",
    "link": "https://finance.yahoo.com/news/novo-nordisk-tumbles-lillys-zepbound-121654605.html"
  },
  {
    "title": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
    "link": "https://finance.yahoo.com/news/trump-vows-us-drug-price-070150001.html"
  },
  {
    "title": "Trending tickers: Tesla, Alibaba, Eli Lilly, Novo Nordisk and Glencore",
    "link": "https://finance.yahoo.com/news/tesla-alibaba-eli-lilly-novo-nordisk-glencore-trending-tickers-093324495.html"
  },
  {
    "title": "Lilly-Purdue partnership to invest $250m in pharma innovation",
    "link": "https://finance.yahoo.com/news/lilly-purdue-partnership-invest-250m-090605067.html"
  },
  {
    "title": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
    "link": "https://finance.yahoo.com/news/asia-pharma-stocks-drop-trump-024422723.html"
  },
  {
    "title": "3 Healthcare Stocks to Keep an Eye On",
    "link": "https://finance.yahoo.com/news/3-healthcare-stocks-keep-eye-044011351.html"
  },
  {
    "title": "Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial",
    "link": "https://finance.yahoo.com/news/eli-lillys-zepbound-outperforms-novo-220619920.html"
  },
  {
    "title": "Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine",
    "link": "https://finance.yahoo.com/news/zepbound-tirzepatide-showed-superior-weight-220100638.html"
  },
  {
    "title": "President Trump Just Announced Terrible News for Eli Lilly Investors",
    "link": "https://finance.yahoo.com/news/president-trump-just-announced-terrible-112300678.html"
  },
  {
    "title": "Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030",
    "link": "https://finance.yahoo.com/news/prediction-2-stocks-join-trillion-100500983.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Income Stock to Invest in Now?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-080803923.html"
  },
  {
    "title": "PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co",
    "link": "https://finance.yahoo.com/news/primecap-managements-strategic-moves-closer-230625566.html"
  },
  {
    "title": "Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down",
    "link": "https://finance.yahoo.com/news/nektar-q1-loss-wider-expected-130800407.html"
  },
  {
    "title": "Wall Street Brings the Bitcoin-Versus-Gold Clash to ETF Masses",
    "link": "https://finance.yahoo.com/news/wall-street-brings-bitcoin-versus-121814642.html"
  },
  {
    "title": "Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation",
    "link": "https://finance.yahoo.com/news/lilly-plans-expand-purdue-university-120000701.html"
  },
  {
    "title": "Eli Lilly extends Purdue alliance; EMA investigates Valneva shot",
    "link": "https://finance.yahoo.com/news/eli-lilly-extends-purdue-alliance-110000057.html"
  },
  {
    "title": "4 No-Brainer Stocks to Buy Right Now",
    "link": "https://finance.yahoo.com/news/4-no-brainer-stocks-buy-103000501.html"
  },
  {
    "title": "Haya secures $65m in Series A funds to advance heart failure treatment",
    "link": "https://finance.yahoo.com/news/haya-secures-65m-series-funds-092614401.html"
  },
  {
    "title": "One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years",
    "link": "https://finance.yahoo.com/news/one-largest-teacher-pension-funds-220500957.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-announces-173901283.html"
  },
  {
    "title": "Top Stock Movers Now: AB InBev, Molson Coors, Eli Lilly, and More",
    "link": "https://finance.yahoo.com/news/top-stock-movers-now-ab-155934659.html"
  },
  {
    "title": "A Look at Pharma ETFs After Strong Q1 Earnings",
    "link": "https://finance.yahoo.com/news/look-pharma-etfs-strong-q1-155000613.html"
  },
  {
    "title": "Eli Lilly falls, Arm reacts to chip curbs, D-Wave skyrockets",
    "link": "https://finance.yahoo.com/video/eli-lilly-falls-arm-reacts-143633414.html"
  },
  {
    "title": "Post-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy",
    "link": "https://finance.yahoo.com/news/post-earnings-dip-why-beaten-130500621.html"
  },
  {
    "title": "Eli Lilly's (NYSE:LLY) Solid Earnings Are Supported By Other Strong Factors",
    "link": "https://finance.yahoo.com/news/eli-lillys-nyse-lly-solid-113712361.html"
  },
  {
    "title": "Lilly announces transitions in executive leadership",
    "link": "https://finance.yahoo.com/news/lilly-announces-transitions-executive-leadership-104500401.html"
  },
  {
    "title": "Down Nearly 20%: Should You Buy the Dip on Eli Lilly?",
    "link": "https://finance.yahoo.com/news/down-nearly-20-buy-dip-085100073.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-bull-171727157.html"
  },
  {
    "title": "Why Novo Nordisk missed its sales estimates on weight-loss drug Wegovy: CEO",
    "link": "https://finance.yahoo.com/news/why-novo-nordisk-missed-its-sales-estimates-on-weight-loss-drug-wegovy-ceo-164318940.html"
  },
  {
    "title": "Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up",
    "link": "https://finance.yahoo.com/news/novo-nordisk-q1-earnings-match-142900915.html"
  },
  {
    "title": "Jim Cramer Says Eli Lilly and Company (LLY) CEO David Ricks Is ‘Very Conservative’",
    "link": "https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-142423163.html"
  },
  {
    "title": "Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise",
    "link": "https://finance.yahoo.com/m/761a85ae-7e36-3fd3-a6f2-64763ae3ba70/novo-nordisk-stock-jumps.html"
  },
  {
    "title": "Company News for May 7, 2025",
    "link": "https://finance.yahoo.com/news/company-news-may-7-2025-132800349.html"
  },
  {
    "title": "Novo Nordisk beats on Q1 earnings, cuts 2025 outlook",
    "link": "https://finance.yahoo.com/news/novo-nordisk-beats-on-q1-earnings-cuts-2025-outlook-105011679.html"
  },
  {
    "title": "Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.",
    "link": "https://finance.yahoo.com/m/a4bec800-6f4b-30e9-8edf-e6305a9166c4/trump-is-threatening-big.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Declares US$1.50 Second Quarter Dividend For 2025",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-declares-174911638.html"
  },
  {
    "title": "Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers.",
    "link": "https://finance.yahoo.com/m/4905bd6c-d6c2-31c3-8bdf-25145b8cfb69/trump-sets-pharma-tariffs.html"
  },
  {
    "title": "Eli Lilly signs $415m deal for Alchemab’s ALS therapy",
    "link": "https://finance.yahoo.com/news/eli-lilly-signs-415m-deal-163807154.html"
  },
  {
    "title": "Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-outlook-140000811.html"
  },
  {
    "title": "Mutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling Name",
    "link": "https://finance.yahoo.com/m/8ab82a95-3c91-38aa-a350-bb1eb84a08b2/mutual-funds-gobble-up-eli.html"
  },
  {
    "title": "Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks",
    "link": "https://finance.yahoo.com/m/6c5668d6-05c3-37a6-8af6-c6146e6b299b/stocks-to-buy-and-watch-top.html"
  },
  {
    "title": "Bluebird pleads for deal support; Unity, Mersana lay off staff",
    "link": "https://finance.yahoo.com/news/bluebird-pleads-deal-support-unity-101900344.html"
  },
  {
    "title": "2 Mega-Cap Stocks with Solid Fundamentals and 1 to Keep Off Your Radar",
    "link": "https://finance.yahoo.com/news/2-mega-cap-stocks-solid-043633449.html"
  },
  {
    "title": "Lilly declares second-quarter 2025 dividend",
    "link": "https://finance.yahoo.com/news/lilly-declares-second-quarter-2025-164700818.html"
  },
  {
    "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-eli-lilly-130014274.html"
  },
  {
    "title": "With compounders out of the way, Lilly and Novo go after each other",
    "link": "https://finance.yahoo.com/news/compounders-way-lilly-novo-other-070528387.html"
  },
  {
    "title": "Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations",
    "link": "https://finance.yahoo.com/news/eli-lilly-first-quarter-2025-141048396.html"
  },
  {
    "title": "What is CVS? 'We are ... working through that very question'",
    "link": "https://finance.yahoo.com/news/what-is-cvs-we-are--working-through-that-very-question-133003590.html"
  },
  {
    "title": "Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?",
    "link": "https://finance.yahoo.com/news/trump-administration-cause-abbvie-eli-084900783.html"
  },
  {
    "title": "Investing.com’s stocks of the week",
    "link": "https://finance.yahoo.com/news/investing-com-stocks-week-093002217.html"
  },
  {
    "title": "Novo Nordisk shares jump as FDA accepts oral Wegovy application",
    "link": "https://finance.yahoo.com/news/novo-nordisk-shares-jump-fda-194836291.html"
  },
  {
    "title": "US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss",
    "link": "https://finance.yahoo.com/news/us-fda-accepts-novo-nordisks-184103062.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Announces Promising Trial Data And Updates 2025 Guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-announces-174607932.html"
  },
  {
    "title": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
    "link": "https://finance.yahoo.com/m/64ec4ca8-6882-3966-87c1-a6c7fec387aa/trump-says-drug-tariffs-are.html"
  },
  {
    "title": "Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-viking-therapeutics-155545062.html"
  },
  {
    "title": "Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.",
    "link": "https://finance.yahoo.com/m/bbeeee31-0cab-36da-b0c1-1bcee50f84f1/eli-lilly%E2%80%99s-stock-selloff-is.html"
  },
  {
    "title": "Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says",
    "link": "https://finance.yahoo.com/news/eli-lilly-apos-zepbound-likely-151239228.html"
  },
  {
    "title": "Eli Lilly Bounces Back. Zepbound Taking A Back Seat To Novo Nordisk's Wegovy At CVS.",
    "link": "https://finance.yahoo.com/m/e4d3bb24-9866-32c8-a5cd-88be4b1110b2/eli-lilly-bounces-back-.html"
  },
  {
    "title": "Eli Lilly stock sell-off was 'overreaction': Analysts",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-sell-off-was-overreaction-analysts-141331064.html"
  },
  {
    "title": "Lilly to participate in Bank of America Securities 2025 Healthcare Conference",
    "link": "https://finance.yahoo.com/news/lilly-participate-bank-america-securities-140000300.html"
  },
  {
    "title": "Update: Eli Lilly Brushes Off CVS Decision to Drop Zepbound Coverage",
    "link": "https://finance.yahoo.com/news/eli-lilly-brushes-off-cvs-125156949.html"
  },
  {
    "title": "Is Novo Nordisk Stock a Buy?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-stock-buy-104500581.html"
  },
  {
    "title": "Company News for May 2, 2025",
    "link": "https://finance.yahoo.com/news/company-news-may-2-2025-095800842.html"
  },
  {
    "title": "Eli Lilly and Co (LLY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...",
    "link": "https://finance.yahoo.com/news/eli-lilly-co-lly-q1-071142866.html"
  },
  {
    "title": "S&P 500 Gains and Losses Today: Index Rises After Strong Start to Big Tech Earnings",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-202908369.html"
  },
  {
    "title": "Eli Lilly Shares Tumble 10% After Q1 Earnings Miss Wall Street Estimates",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-tumble-10-194311076.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Growth Stock to Buy for the Next 3 Years?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-191429173.html"
  },
  {
    "title": "Why Eli Lilly (LLY) Stock Is Nosediving",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-lly-stock-184503351.html"
  },
  {
    "title": "Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'",
    "link": "https://finance.yahoo.com/news/eli-lilly-ceo-waves-off-cvs-novo-nordisk-deal-it-feels-a-little-like-last-decade-184222200.html"
  },
  {
    "title": "3 things we've learned from healthcare earnings",
    "link": "https://finance.yahoo.com/video/3-things-weve-learned-healthcare-180401035.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Reports Strong Q1 Growth Despite Lowered 2025 EPS Guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-reports-180259196.html"
  },
  {
    "title": "Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy",
    "link": "https://finance.yahoo.com/news/lilly-q1-2025-revenue-jumps-174447435.html"
  },
  {
    "title": "Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health",
    "link": "https://finance.yahoo.com/news/lilly-star-weight-loss-drug-170227088.html"
  },
  {
    "title": "Why Eli Lilly Stock Is Sinking Today",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-stock-sinking-164953232.html"
  },
  {
    "title": "Eli Lilly slides, CVS earnings, Qualcomm's soft guidance",
    "link": "https://finance.yahoo.com/video/eli-lilly-slides-cvs-earnings-161935240.html"
  },
  {
    "title": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
    "link": "https://finance.yahoo.com/news/declare-victory-and-move-on-eli-lilly-ceo-on-trump-tariff-threat-160646465.html"
  },
  {
    "title": "Top Midday Stories: Microsoft, Meta Earnings Top Estimates; Eli Lilly Cuts Guidance Despite Strong Q1 Earnings",
    "link": "https://finance.yahoo.com/news/top-midday-stories-microsoft-meta-155528986.html"
  },
  {
    "title": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
    "link": "https://finance.yahoo.com/news/llys-q1-earnings-miss-mounjaro-155100125.html"
  },
  {
    "title": "Why the Eli Lilly sell-off may be an 'overreaction'",
    "link": "https://finance.yahoo.com/video/why-eli-lilly-sell-off-155031468.html"
  },
  {
    "title": "Eli Lilly CEO Urges Trump to Ease Up on Tariffs, Extend 2017 Tax Cuts",
    "link": "https://finance.yahoo.com/m/4b159ce0-28d9-3ffe-8614-0d54c1a7e2ae/eli-lilly-ceo-urges-trump-to.html"
  },
  {
    "title": "Initial Claims More Than Expectations",
    "link": "https://finance.yahoo.com/news/initial-claims-more-expectations-150900489.html"
  },
  {
    "title": "Eli Lilly's Q1 win outweighed by Novo's CVS deal",
    "link": "https://finance.yahoo.com/video/eli-lillys-q1-win-outweighed-140954770.html"
  },
  {
    "title": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "link": "https://finance.yahoo.com/m/0568b560-5011-321d-817f-c1d3f74d68ee/eli-lilly-earnings-beat.html"
  },
  {
    "title": "Here's What Key Metrics Tell Us About Lilly (LLY) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-133036555.html"
  },
  {
    "title": "Eli Lilly Lowers 2025 Earnings Outlook Despite Stronger-Than-Expected First-Quarter Results",
    "link": "https://finance.yahoo.com/news/eli-lilly-lowers-2025-earnings-130652292.html"
  },
  {
    "title": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-despite-earnings-beat-reaffirmed-2025-guidance-125448495.html"
  },
  {
    "title": "If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?",
    "link": "https://finance.yahoo.com/m/d615c35b-9343-3e67-975a-923b1fe5cf7b/if-a-recession-hits-will.html"
  },
  {
    "title": "Lower Taxes Could Bring More Drug Production to U.S., Says Eli Lilly",
    "link": "https://finance.yahoo.com/m/057a2c94-cd1c-3afb-bcbc-dfbfaabe511f/lower-taxes-could-bring-more.html"
  },
  {
    "title": "Eli Lilly (LLY) Q1 Earnings Lag Estimates",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-q1-earnings-115506741.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Beats Q1 Sales Targets",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-beats-114819224.html"
  },
  {
    "title": "Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds",
    "link": "https://finance.yahoo.com/m/481e4c33-cb1e-3e7a-bb1d-403b3a1fcebb/eli-lilly-revenue-up-on.html"
  },
  {
    "title": "Eli Lilly Stock Drops as Lowered Profit Outlook Outweighs Solid Q1 Results",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-lowered-111022972.html"
  },
  {
    "title": "Lilly: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/lilly-q1-earnings-snapshot-105817352.html"
  },
  {
    "title": "Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge",
    "link": "https://finance.yahoo.com/news/eli-lilly-beats-q1-profit-105334205.html"
  },
  {
    "title": "Lilly reports first-quarter 2025 financial results and highlights pipeline momentum",
    "link": "https://finance.yahoo.com/news/lilly-reports-first-quarter-2025-104500297.html"
  },
  {
    "title": "CVS posts Q1 earnings beat, raises full-year guidance",
    "link": "https://finance.yahoo.com/news/cvs-posts-q1-earnings-beat-raises-full-year-guidance-103035785.html"
  },
  {
    "title": "Trump Says Tariffs Politically Risky, But He’s Not Rushing Deals",
    "link": "https://finance.yahoo.com/news/trump-says-tariffs-politically-risky-014826903.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): Jim Cramer Rides the GLP-1 Wave — “Hundreds of Thousands Are Filling Scripts Weekly”",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-jim-000250512.html"
  },
  {
    "title": "Amazon and Apple earnings coverage, Eli Lilly: What to Watch",
    "link": "https://finance.yahoo.com/video/amazon-apple-earnings-coverage-eli-230052060.html"
  },
  {
    "title": "Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement?",
    "link": "https://finance.yahoo.com/news/buy-hims-hims-novo-nordisk-204800585.html"
  },
  {
    "title": "Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.",
    "link": "https://finance.yahoo.com/news/viagra-mounjaro-panic-buying-could-112525070.html"
  },
  {
    "title": "Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More",
    "link": "https://finance.yahoo.com/news/eli-lillys-stock-15-heres-095000833.html"
  },
  {
    "title": "Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead",
    "link": "https://finance.yahoo.com/news/why-wegovy-deals-won-t-093000116.html"
  },
  {
    "title": "Myostatin inhibitors target muscle loss prevention to fill gap in GLP-1RA market",
    "link": "https://finance.yahoo.com/news/myostatin-inhibitors-target-muscle-loss-080000028.html"
  },
  {
    "title": "What To Expect From Eli Lilly’s (LLY) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/expect-eli-lilly-lly-q1-070801413.html"
  },
  {
    "title": "Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk",
    "link": "https://finance.yahoo.com/news/hims-hers-stock-surges-wegovy-163634493.html"
  },
  {
    "title": "INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales",
    "link": "https://finance.yahoo.com/news/incy-q1-earnings-revenues-beat-150400883.html"
  },
  {
    "title": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "link": "https://finance.yahoo.com/video/pfizer-offers-longer-term-opportunity-143115195.html"
  },
  {
    "title": "Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-q1-earnings-investors-142000791.html"
  },
  {
    "title": "Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership",
    "link": "https://finance.yahoo.com/news/hims--hers-stock-jumps-on-novo-nordisk-glp-1-partnership-141811461.html"
  },
  {
    "title": "Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss",
    "link": "https://finance.yahoo.com/news/jim-cramer-eli-lilly-company-123821312.html"
  }
]